You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

statin

Showing 1 - 25 of 1,801
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug Adherence Trial (Red yeast rice extract initial therapy followed later on by statin therapy, Statin therapy)

Not yet recruiting
  • Moderate 10-year Atherosclerotic Cardiovascular Disease Risk Patients
  • Red yeast rice extract initial therapy followed later on by statin therapy
  • Statin therapy
  • (no location specified)
Apr 26, 2023

Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)

Not yet recruiting
  • Vaccine Response
  • Atlanta, Georgia
    Hope Clinic
Aug 29, 2023

Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul

Not yet recruiting
  • Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
  • ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
  • high-intensity statin monotherapy (atoravastatin 40mg)
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 21, 2023

Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias Trial (Guideline directed statin therapy, High intensity statin

Not yet recruiting
  • Coronary Artery Calcification
  • +2 more
  • Guideline directed statin therapy
  • High intensity statin plus ezetimibe therapy
  • (no location specified)
Apr 25, 2023

Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • high-intensity statin arm
  • low-intensity statin plus ezetimibe
  • (no location specified)
Oct 12, 2022

Physical Activity Levels and Statin Therapy

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Physical activity monitoring
  • Nijmegen, Netherlands
    Department of Physiology
Nov 15, 2022

Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Statin Adverse Reaction Trial in Tunis (Atorvastatin 40 Mg Oral

Completed
  • Diabetes Mellitus, Type 2
  • +5 more
  • Atorvastatin 40 Mg Oral Tablet
  • Tunis, Tunisia
    University Hospital La Rabta
Apr 7, 2023

Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)

Active, not recruiting
  • Coronary Artery Diseasse
  • fixed high potent statin therapy
  • targeted LDL-C goal statin
  • Seoul, Korea, Republic of
    Division of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022

Extra Alirocumab in Addition to Statin Therapy in Symptomatic

Recruiting
  • Stroke
  • Intracranial Atherosclerotic Stenosis
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Sep 24, 2023

Atherosclerosis Trial in Essen (Medication management app (mediteo m+, Mediteo GmbH, Heidelberg))

Recruiting
  • Atherosclerosis
  • Medication management app (mediteo m+, Mediteo GmbH, Heidelberg)
  • Essen, Nordrhein-Westfalen, Germany
    University Hospital, Essen
Mar 8, 2023

Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)

Recruiting
  • Doxorubicin Induced Cardiomyopathy
  • Atorvastatin 40 Mg Oral Tablet
  • Placebo
  • Cairo, Egypt
    Ain Shams University hospitals
Apr 4, 2023

Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis Trial in Nanjing (Alirocumab, Atorvastatin)

Not yet recruiting
  • Intracranial Atherosclerosis
  • +2 more
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Oct 10, 2023

Coronary Artery Disease Trial in Boston (Rosuvastatin, Colchicine)

Not yet recruiting
  • Coronary Artery Disease
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 28, 2023

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small

Recruiting
  • Lung Cancer
  • Statin
  • Yiwu, Zhejiang, China
    The Fourth Affiliated Hospital of Zhejiang University
Dec 16, 2022

Primary Sclerosing Cholangitis, IBD Trial in Stanford (Rosuvastatin)

Recruiting
  • Primary Sclerosing Cholangitis
  • Inflammatory Bowel Diseases
  • Stanford, California
    Stanford University
Jun 12, 2023

Quality of Life Trial in Tanta (Atorvastatin 20mg, Placebo)

Recruiting
  • Quality of Life
  • Atorvastatin 20mg
  • Placebo
  • Tanta, Egypt
    Tanta University
Nov 3, 2022

Status of Dyslipidemia Following Administration of Statin and

Recruiting
  • Dyslipidemias
  • Statin+Ezetimibe compound
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Nov 7, 2022

Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Trial in Nanjing (Evolocumab, Atorvastatin)

Not yet recruiting
  • Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Feb 14, 2023

Statin Treatment for Primary Prevention Trial in Bern (Statin discontinuation)

Not yet recruiting
  • Statin Treatment for Primary Prevention
  • Statin discontinuation
  • Bern, Switzerland
    University Hospital of Bern, University of Bern
Jul 28, 2022

Tuberculosis Trial in Johannesburg (Pravastatin)

Completed
  • Tuberculosis
  • Johannesburg, South Africa
    Chris Hani Baragwanath Hospital
Sep 26, 2022

Statin Treatment for Primary Prevention Trial in Bern (Statin discontinuation)

Recruiting
  • Statin Treatment for Primary Prevention
  • Statin discontinuation
  • Bern, Switzerland
    University Hospital of Bern, University of Bern
Aug 2, 2022

Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

Recruiting
  • Coronary Artery Disease
  • Dyslipidemias
  • a high dose of statin/ezetimib
  • Yongin, Gyeonggi-do, Korea, Republic of
    Yongin Severance Hospital
Jun 14, 2023

Atheroscleroses, Coronary Trial in Seoul (Rosuvastatin and Ezetimibe, Rosuvastatin)

Active, not recruiting
  • Atheroscleroses, Coronary
  • Seoul, Korea, Republic of
  • +1 more
Oct 1, 2022

Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention Trial in Nanjing (Placebo plus high-intensity

Not yet recruiting
  • Acute Coronary Syndrome
  • +3 more
  • Placebo plus high-intensity statin
  • PCSK 9 Inhibitor plus high-intensity statin
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Aug 1, 2022

Intracerebral Hemorrhage, Statins Trial in Beijing, Baoding (Statin)

Recruiting
  • Intracerebral Hemorrhage
  • Statins
  • Statin
  • Beijing, Beijing, China
  • +2 more
Jun 7, 2022